A comparative study between lateral internal anal sphincterotomy and botulinum toxin injection in the treatment of chronic anal fissure

Abdulqadir M. Zngana; Bawan Hiwa

doi:10.15218/zjms.2021.014

Authors

Abdulqadir M. Zngana Department of Surgery, College of Medicine, Hawler Medical University, Erbil, Iraq
Bawan Hiwa Department of General Surgery, Erbil Teaching Hospital, Erbil, Iraq

DOI:

https://doi.org/10.15218/zjms.2021.014

Keywords:

Chronic anal fissure, Lateral internal sphincterotomy, Botulinum toxin, Complications

Abstract

Background and objective: The gold standard for the treatment of chronic anal fissure is lateral internal sphincterotomy. Botulinum toxin injection provides temporary alleviation of sphincter spasm and allows the fissure to heal. This study aimed to compare the outcomes of lateral internal sphincterotomy and botulinum toxin injection treatments in patients with uncomplicated chronic anal fissure.

Methods: A prospective comparative study was carried out at the surgical unit of Erbil teaching hospital, Erbil, Kurdistan Region of Iraq, from January 2017 to February 2018. Fifty-five patients were enrolled in this study. Five patients were excluded, and the remaining 50 patients were equally divided into two groups. Group A was managed with lateral internal sphincterotomy and group B with botulinum toxin. Postoperative pain relief, bleeding, fissure healing, incontinence, and relapse after six weeks and three months of follow-up were compared.

Results: One month after treatment, 12% of the lateral internal sphincterotomy group had bleeding, while none of the botulinum toxin group (P = 0.234). Two patients (8%) of the lateral internal sphincterotomy group had pain while one (4%) of the botulinum toxin group (P >0.999).Three months after treatment, 4% of the lateral internal sphincterotomy group had bleeding, while none of the botulinum toxin group (P >0.999). None of the lateral internal sphincterotomy group had pain while one (4%) of the botulinum toxin group (P >0.999). Regarding healing, 96% of the lateral internal sphincterotomy group healed, while 92% in the botulinum toxin group (P >0.999).

Conclusion: The outcome of lateral internal sphincterotomy and botulinum toxin were nearly the same, but lateral internal sphincterotomy required hospitalization, period off work, and risk of anesthesia. These risks were absent in botulinum toxin injection.

Metrics

Metrics Loading ...

References

Whatley JZ, Tang SJ, Glover PH, Davis ED, Jex KT, Wu R, et al. Management of complicated chronic anal fissures with high-dose circumferential chemodenervation (HDCC) of the internal anal sphincter. Int J Surg 2015; 24:24–6.

Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev 2012; 2012(2):CD003431.

Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: Management of benign anorectal disorders. Am J Gastroenterol 2014; 109(8):1141–57.

Kwaan MR, Stewart DB, Dunn KB. Colon, Rectum, and Anus. Text book of Schwart,s principle of surgery. 11th ed. United States of America: McGraw-Hill Education; 2019. P.1313.

Aarons CB, Sentovich SM. Anorectum. Text book of Current diagnosis and treatment surgery. 14thed. United States of America:McGraw-Hill Education; 2015. P. 746.

Halahakoon VC, Pitt JP. Anal advancement flap and botulinum toxin A (BT) for chronic anal fissure (CAF). Int J Colorectal Dis 2014; 29(9):1175–7.

Glover PH, Tang SJ, Whatley JZ, Davis ED, Jex KT, Wu R, et al. High-dose circumferential chemodenervation of the internal anal sphincter: A new treatment modality for uncomplicated chronic anal fissure: A retrospective cohort study (with video). Int J Surg 2015; 23:1–4.

Bhardwaj R, Drye E, Vaizey C. Novel delivery of botulinum toxin for the treatment of anal fissures. Colorectal Dis 2006; 8(4):360–4.

Piccinni G, Poli E, Angrisano A, Sciusco A, Testini M. Botox for chronic anal fissure: is it useful? A clinical experience with mid-term follow-up. Acta Biomed 2009; 80(3):238–42.

Dhawan S, Chopra S. Nonsurgical Approaches for the Treatment of Anal Fissures: CME. Am J Gastroenterol 2007; 102(6):1312–21.

Iswariah H, Stephens J, Rieger N, Rodda D, Hewett P. Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano. ANZ journal of surgery 2005; 75(7):553–5.

Jones OM, Brading AF, Mortensen NM. Mechanism of action of botulinum toxin on the internal anal sphincter. Br J Surg 2004; 91(2):224–8.

Daniel F, Siproudhis L, Atienza P. Botulinum toxin and chronic anal fissure. Gastroen Clin Biol 2006; 30(5):687–95.

Valizadeh N, Jalaly NY, Hassanzadeh M, Kamani F, Dadvar Z, Azizi S, et al. Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial. Langenbeck's Arch Surg 2012; 397(7):1093–8.

Witte ME, Klaase JM. Botulinum toxin A injection in ISDN ointment-resistant chronic anal fissures. Dig Surg 2007; 24(3):197–201.

Minguez M, Herreros B, Sanchiz V, Mora F, Benages A, EspiA, et al. Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology 2002; 123(1):112–7.

Arroyo A, Pérez F, Serrano P, Candela F, Lacueva J, Calpena R. Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study. Am J Surg 2005; 189(4):429–34.

Yiannakopoulou E. Botulinum toxin and anal fissure: efficacy and safety systematic review. Int J Colorectal Dis 2012; 27(1):1–9.

Sajid MS, Hunte S, Hippolyte S, Kiri VA, Maringe C, Baig MK. Comparison of surgical vs. chemical sphincterotomy using botulinum toxin for the treatment of chronic anal fissure: a meta-analysis. Colorectal Dis 2008; 10(6):547–52.

Sinha R, Kaiser AM. Efficacy of management algorithm for reducing need for sphincterotomy in chronic anal fissures. Colorectal Dis 2012; 14(6):760–4.

Witte ME, Klaase JM. Botulinum toxin A injection in ISDN ointment-resistant chronic anal fissures. Dig Surg 2007; 24(3):197–201.

Nasr M, Ezzat H, Elsebae M. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a randomized controlled trial. World J Surg 2010; 34(11):2730–4.

Berkel AE, Rosman C, Koop R, van Duijvendijk P, van der Palen J, Klaase JM. Isosorbide dinitrate ointment vs. botulinum toxin A (D ysport®) as the primary treatment for chronic anal fissure: a randomized multicentre study. Colorectal Dis 2014; 16(10):O360–6.

Chen HL, Woo XB, Wang HS, Lin YJ, Luo HX, Chen YH, et al. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials. Tech Coloproctol 2014; 18(8):693–8.